PLT Health Solutions, Inc. announced that it will be presenting clinical study results for its Serezin™ Restorative Sleep + Pain Relief ingredient at the American Academy of Sleep Medicine Conference being held June 7-11 in Seattle, WA USA. Dawna Salter-Farfan, PhD, RD, PLT’s Senior Clinical Research Manager, will be conducting a  poster session Wednesday, 6/11/2025, at 10:00 AM during the Clinical Sleep Science and Practice section. The session will cover results of a recent clinical trial on Serezin and will present data specifically on results with women. An abstract entitled  An Herbal Supplement Improves Restorative Sleep and Sleep Quality, Elevates Mood, and Increases Total Sleep Time,“  was published in the May edition of the journal SLEEP.

The amendment to the German Medical Fee Schedule (GOÄ) recently passed at the 129th Doctors' Assembly in Leipzig has caused considerable concern in laboratory medicine. In an exclusive interview with MedLabPortal, Priv.-Doz. Dr. med. Matthias Orth, Chief Physician of the Institute for Laboratory Medicine at Marienhospital Stuttgart, expressed criticism of the reform's impact on his field. Orth, a specialist in laboratory medicine, medical hygiene, and hemostasiology, warned of a deterioration in patient care and rising treatment costs. The adoption of the GOÄ amendment was not surprising, according to Orth, as there was massive pressure on the delegates beforehand to accept the reform. General practitioners, who hope to benefit from the new regulation, as well as employed and retired doctors who are not directly affected, formed the majority. The aim of the reform is to curb treatment costs in the private health insurance sector. However, the planned devaluation of technical disciplines such as laboratory medicine below cost price will...

B cells play a dual role in tumorigenesis: they act as both allies and adversaries within the tumor microenvironment (TME). Their anti-tumor functions include recognizing tumor-associated antigens, producing antibodies, activating cytotoxic immune responses, and forming tertiary lymphoid structures (TLS), which enhance immune cell coordination. Tumor-infiltrating B cells (TIL-Bs) within TLS contribute to improved patient survival and better responses to immunotherapies by promoting antibody class switching, somatic hypermutation, and cytokine secretion, which in turn recruit and activate T cells, natural killer (NK) cells, and dendritic cells (DCs). Antibodies produced by B cells mediate complement-dependent cytotoxicity (CDC), antibody-dependent cellular phagocytosis (ADCP), and antibody-dependent cellular cytotoxicity (ADCC), directly eliminating tumor cells. Additionally, B cells present antigens to T cells and secrete cytokines such as IFN-γ and CXCL13, thereby enhancing anti-tumor immunity. However, regulatory B cells (Bregs) and other subsets suppress immune responses by secreting IL-10, TGF-β… 

Insulin resistance is becoming increasingly common due to a combination of lifestyle factors, genetics, and medical conditions. Many of these risk factors also play a role in abnormal uterine bleeding. A new study aims to demonstrate the link between these two factors to better predict abnormal uterine bleeding. The study’s findings were published online today in  Menopause , the journal of The Menopause Society. Abnormal uterine bleeding has become more common, affecting approximately 30% of women of reproductive age. It costs the healthcare system more than $34 billion annually, not to mention the additional economic burden of increased work absenteeism and overall reduced quality of life. Currently, much of the research in this area focuses on the diagnosis and treatment of abnormal uterine bleeding rather than prevention, with a focus on reducing cardiovascular risk factors as a treatment method. At the same time, cases of insulin resistance are increasing,…